nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—ABCG2—Sulfasalazine—ulcerative colitis	0.119	0.255	CbGbCtD
Leflunomide—ABCG2—Hydrocortisone—ulcerative colitis	0.0957	0.205	CbGbCtD
Leflunomide—CYP1A2—Nicotine—ulcerative colitis	0.0633	0.135	CbGbCtD
Leflunomide—ABCG2—Dexamethasone—ulcerative colitis	0.0595	0.127	CbGbCtD
Leflunomide—CYP2C9—Nicotine—ulcerative colitis	0.057	0.122	CbGbCtD
Leflunomide—CYP2C9—Cholecalciferol—ulcerative colitis	0.0511	0.109	CbGbCtD
Leflunomide—CYP2C9—Dexamethasone—ulcerative colitis	0.0221	0.0473	CbGbCtD
Leflunomide—Niflumic Acid—PTGS1—ulcerative colitis	0.00392	0.636	CrCbGaD
Leflunomide—DHODH—lymphoid tissue—ulcerative colitis	0.00383	0.151	CbGeAlD
Leflunomide—PTK2B—smooth muscle tissue—ulcerative colitis	0.00304	0.12	CbGeAlD
Leflunomide—DHODH—liver—ulcerative colitis	0.00282	0.111	CbGeAlD
Leflunomide—AHR—smooth muscle tissue—ulcerative colitis	0.0025	0.0986	CbGeAlD
Leflunomide—PTK2B—lymphoid tissue—ulcerative colitis	0.00243	0.0959	CbGeAlD
Leflunomide—PTK2B—digestive system—ulcerative colitis	0.0024	0.0947	CbGeAlD
Leflunomide—Niflumic Acid—PTGS2—ulcerative colitis	0.00224	0.364	CrCbGaD
Leflunomide—AHR—digestive system—ulcerative colitis	0.00197	0.0779	CbGeAlD
Leflunomide—PTK2B—liver—ulcerative colitis	0.00179	0.0706	CbGeAlD
Leflunomide—AHR—liver—ulcerative colitis	0.00147	0.058	CbGeAlD
Leflunomide—PTK2B—Signaling events mediated by VEGFR1 and VEGFR2—CALM3—ulcerative colitis	0.00116	0.00994	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.00115	0.0098	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.00114	0.00976	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	0.00107	0.00914	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL17A—ulcerative colitis	0.00103	0.00882	CbGpPWpGaD
Leflunomide—PTK2B—Osteopontin-mediated events—RELA—ulcerative colitis	0.000954	0.00816	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—GHRL—ulcerative colitis	0.000918	0.00786	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—RIPK2—ulcerative colitis	0.000915	0.00782	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—ADCY5—ulcerative colitis	0.000896	0.00766	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000891	0.00762	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—ADCY5—ulcerative colitis	0.000885	0.00757	CbGpPWpGaD
Leflunomide—PTK2B—IL-7 Signaling Pathway—STAT3—ulcerative colitis	0.000859	0.00735	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1R2—ulcerative colitis	0.000835	0.00714	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	0.000832	0.00711	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000832	0.00711	CbGpPWpGaD
Leflunomide—PTK2B—Osteopontin-mediated events—MMP9—ulcerative colitis	0.000813	0.00696	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—CALM3—ulcerative colitis	0.000809	0.00692	CbGpPWpGaD
Leflunomide—PTK2B—Osteopontin-mediated events—NFKB1—ulcerative colitis	0.000805	0.00688	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—MMP1—ulcerative colitis	0.000793	0.00678	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—RIPK2—ulcerative colitis	0.000791	0.00676	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—MMP1—ulcerative colitis	0.000773	0.00661	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—CALM3—ulcerative colitis	0.000763	0.00653	CbGpPWpGaD
Leflunomide—CYP1A2—digestive system—ulcerative colitis	0.000735	0.0291	CbGeAlD
Leflunomide—DHODH—Metabolism—CHP1—ulcerative colitis	0.000723	0.00619	CbGpPWpGaD
Leflunomide—PTK2B—FGF signaling pathway—CDH1—ulcerative colitis	0.000721	0.00617	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	0.000718	0.00614	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—NOD2—ulcerative colitis	0.000717	0.00613	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL7R—ulcerative colitis	0.00071	0.00607	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—JAK2—ulcerative colitis	0.000706	0.00604	CbGpPWpGaD
Leflunomide—CYP2C9—digestive system—ulcerative colitis	0.000698	0.0276	CbGeAlD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000689	0.0059	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—PPARG—ulcerative colitis	0.000682	0.00583	CbGpPWpGaD
Leflunomide—PTK2B—IL-2 Signaling Pathway—IL2—ulcerative colitis	0.000674	0.00576	CbGpPWpGaD
Leflunomide—PTK2B—Signaling of Hepatocyte Growth Factor Receptor—STAT3—ulcerative colitis	0.000672	0.00574	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—DLD—ulcerative colitis	0.000624	0.00534	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—IFNG—ulcerative colitis	0.00062	0.00531	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL2—ulcerative colitis	0.000616	0.00527	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—HLA-DRB1—ulcerative colitis	0.000596	0.0051	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	0.000577	0.00493	CbGpPWpGaD
Leflunomide—ABCG2—liver—ulcerative colitis	0.000569	0.0225	CbGeAlD
Leflunomide—PTK2B—IL-2 Signaling Pathway—STAT3—ulcerative colitis	0.000567	0.00485	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—JAK2—ulcerative colitis	0.000559	0.00478	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—IL2—ulcerative colitis	0.000551	0.00471	CbGpPWpGaD
Leflunomide—CYP1A2—liver—ulcerative colitis	0.000548	0.0217	CbGeAlD
Leflunomide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—ulcerative colitis	0.000546	0.00467	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—JAK2—ulcerative colitis	0.000545	0.00466	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—RELA—ulcerative colitis	0.000534	0.00457	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—RELA—ulcerative colitis	0.000528	0.00451	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—ulcerative colitis	0.000524	0.00448	CbGpPWpGaD
Leflunomide—PTK2B—FGF signaling pathway—MMP9—ulcerative colitis	0.000522	0.00446	CbGpPWpGaD
Leflunomide—CYP2C9—liver—ulcerative colitis	0.00052	0.0206	CbGeAlD
Leflunomide—PTK2B—LPA receptor mediated events—CXCL8—ulcerative colitis	0.000503	0.00431	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IRF5—ulcerative colitis	0.000502	0.00429	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—PPARG—ulcerative colitis	0.000481	0.00412	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IRF8—ulcerative colitis	0.00048	0.0041	CbGpPWpGaD
Leflunomide—PTK2B—FGF signaling pathway—STAT3—ulcerative colitis	0.000464	0.00397	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—STAT3—ulcerative colitis	0.000464	0.00397	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—MMP9—ulcerative colitis	0.000455	0.00389	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—NFKB1—ulcerative colitis	0.000451	0.00385	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—DEFA6—ulcerative colitis	0.00045	0.00385	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—NFKB1—ulcerative colitis	0.000445	0.00381	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—JAK2—ulcerative colitis	0.000444	0.0038	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—PTPN2—ulcerative colitis	0.000439	0.00375	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—ABCB1—ulcerative colitis	0.00043	0.00368	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—CD4—ulcerative colitis	0.000421	0.0036	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—STAT3—ulcerative colitis	0.000418	0.00358	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	0.000413	0.00353	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—ulcerative colitis	0.000408	0.00349	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—RELA—ulcerative colitis	0.000407	0.00348	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—STAT3—ulcerative colitis	0.0004	0.00342	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—CD4—ulcerative colitis	0.000398	0.00341	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TGFB1—ulcerative colitis	0.000388	0.00332	CbGpPWpGaD
Leflunomide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000388	0.00332	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000388	0.00331	CbGpPWpGaD
Leflunomide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000369	0.00316	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—RIPK2—ulcerative colitis	0.000369	0.00316	CbGpPWpGaD
Leflunomide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000369	0.00315	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL1B—ulcerative colitis	0.000368	0.00314	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—MMP9—ulcerative colitis	0.000366	0.00313	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—JAK2—ulcerative colitis	0.000366	0.00313	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—JAK2—ulcerative colitis	0.000363	0.0031	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TNF—ulcerative colitis	0.000362	0.0031	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL6—ulcerative colitis	0.000362	0.0031	CbGpPWpGaD
Leflunomide—PTK2B—Cell-Cell communication—CDH1—ulcerative colitis	0.000357	0.00305	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—RELA—ulcerative colitis	0.000352	0.00301	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000346	0.00296	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—JAK2—ulcerative colitis	0.000345	0.00295	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—NFKB1—ulcerative colitis	0.000343	0.00293	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HERC2—ulcerative colitis	0.000341	0.00292	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—NOD2—ulcerative colitis	0.000334	0.00286	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000331	0.00283	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000329	0.00281	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—STAT3—ulcerative colitis	0.000326	0.00279	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MASP2—ulcerative colitis	0.000326	0.00278	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ICOSLG—ulcerative colitis	0.000326	0.00278	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—VCAM1—ulcerative colitis	0.000321	0.00274	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DQA1—ulcerative colitis	0.00032	0.00274	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1B—ulcerative colitis	0.000318	0.00272	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL2—ulcerative colitis	0.000317	0.00271	CbGpPWpGaD
Leflunomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000316	0.0027	CbGpPWpGaD
Leflunomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000315	0.00269	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—TP53—ulcerative colitis	0.000305	0.00261	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PTGS1—ulcerative colitis	0.000302	0.00258	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—NFKB1—ulcerative colitis	0.000296	0.00254	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—IL6—ulcerative colitis	0.000292	0.0025	CbGpPWpGaD
Leflunomide—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000291	0.00249	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—DEFA5—ulcerative colitis	0.00029	0.00248	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TNFRSF14—ulcerative colitis	0.00029	0.00248	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—JAK2—ulcerative colitis	0.000288	0.00247	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—TGFB1—ulcerative colitis	0.000286	0.00244	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	0.000283	0.00242	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ARPC2—ulcerative colitis	0.000281	0.0024	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—RELA—ulcerative colitis	0.000279	0.00239	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1R2—ulcerative colitis	0.000273	0.00233	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CALM3—ulcerative colitis	0.000272	0.00232	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000272	0.00232	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—STAT3—ulcerative colitis	0.000266	0.00228	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—JAK2—ulcerative colitis	0.000262	0.00224	CbGpPWpGaD
Leflunomide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000257	0.0022	CbGpPWpGaD
Leflunomide—ABCG2—Fluoropyrimidine Activity—TP53—ulcerative colitis	0.000244	0.00209	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CARD9—ulcerative colitis	0.000237	0.00202	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NFKB1—ulcerative colitis	0.000236	0.00201	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000232	0.00198	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL7R—ulcerative colitis	0.000232	0.00198	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DRB1—ulcerative colitis	0.000228	0.00195	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—TP53—ulcerative colitis	0.000225	0.00193	CbGpPWpGaD
Leflunomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.00022	0.00188	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—ICAM1—ulcerative colitis	0.000219	0.00187	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL6—ulcerative colitis	0.000215	0.00184	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—STAT3—ulcerative colitis	0.000212	0.00181	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ABCB1—ulcerative colitis	0.000211	0.00181	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—IL6—ulcerative colitis	0.000206	0.00176	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000204	0.00174	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000204	0.00174	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ADCY5—ulcerative colitis	0.000197	0.00169	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—STAT3—ulcerative colitis	0.000193	0.00165	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—ulcerative colitis	0.000187	0.0016	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—ulcerative colitis	0.000186	0.00159	CbGpPWpGaD
Leflunomide—Vertigo—Triamcinolone—ulcerative colitis	0.000183	0.000477	CcSEcCtD
Leflunomide—Hypersensitivity—Mesalazine—ulcerative colitis	0.000183	0.000476	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000183	0.000476	CcSEcCtD
Leflunomide—Vertigo—Methylprednisolone—ulcerative colitis	0.000182	0.000475	CcSEcCtD
Leflunomide—Discomfort—Hydrocortisone—ulcerative colitis	0.000182	0.000474	CcSEcCtD
Leflunomide—Connective tissue disorder—Prednisone—ulcerative colitis	0.000181	0.000473	CcSEcCtD
Leflunomide—Nausea—Budesonide—ulcerative colitis	0.000181	0.000472	CcSEcCtD
Leflunomide—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000181	0.000471	CcSEcCtD
Leflunomide—Dizziness—Azathioprine—ulcerative colitis	0.00018	0.000469	CcSEcCtD
Leflunomide—Asthenia—Mesalazine—ulcerative colitis	0.000178	0.000464	CcSEcCtD
Leflunomide—Cough—Triamcinolone—ulcerative colitis	0.000177	0.000463	CcSEcCtD
Leflunomide—PTK2B—Signaling by VEGF—IL6—ulcerative colitis	0.000177	0.00151	CbGpPWpGaD
Leflunomide—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000176	0.00046	CcSEcCtD
Leflunomide—Tachycardia—Prednisolone—ulcerative colitis	0.000176	0.000459	CcSEcCtD
Leflunomide—Hypertension—Triamcinolone—ulcerative colitis	0.000176	0.000458	CcSEcCtD
Leflunomide—Pruritus—Mesalazine—ulcerative colitis	0.000175	0.000457	CcSEcCtD
Leflunomide—Hypertension—Methylprednisolone—ulcerative colitis	0.000175	0.000457	CcSEcCtD
Leflunomide—Infection—Hydrocortisone—ulcerative colitis	0.000175	0.000457	CcSEcCtD
Leflunomide—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000175	0.000455	CcSEcCtD
Leflunomide—Myalgia—Triamcinolone—ulcerative colitis	0.000173	0.000452	CcSEcCtD
Leflunomide—Vomiting—Azathioprine—ulcerative colitis	0.000173	0.000451	CcSEcCtD
Leflunomide—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000173	0.000451	CcSEcCtD
Leflunomide—Myalgia—Methylprednisolone—ulcerative colitis	0.000173	0.000451	CcSEcCtD
Leflunomide—Arthralgia—Methylprednisolone—ulcerative colitis	0.000173	0.000451	CcSEcCtD
Leflunomide—PTK2B—Immune System—ITGAL—ulcerative colitis	0.000173	0.00148	CbGpPWpGaD
Leflunomide—Eye disorder—Prednisone—ulcerative colitis	0.000173	0.00045	CcSEcCtD
Leflunomide—Anxiety—Methylprednisolone—ulcerative colitis	0.000172	0.000449	CcSEcCtD
Leflunomide—Tachycardia—Hydrocortisone—ulcerative colitis	0.000172	0.000449	CcSEcCtD
Leflunomide—Rash—Azathioprine—ulcerative colitis	0.000172	0.000448	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000172	0.000447	CcSEcCtD
Leflunomide—Dermatitis—Azathioprine—ulcerative colitis	0.000171	0.000447	CcSEcCtD
Leflunomide—Skin disorder—Hydrocortisone—ulcerative colitis	0.000171	0.000447	CcSEcCtD
Leflunomide—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000171	0.000447	CcSEcCtD
Leflunomide—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000171	0.000447	CcSEcCtD
Leflunomide—Discomfort—Triamcinolone—ulcerative colitis	0.000171	0.000446	CcSEcCtD
Leflunomide—Discomfort—Methylprednisolone—ulcerative colitis	0.000171	0.000445	CcSEcCtD
Leflunomide—Headache—Azathioprine—ulcerative colitis	0.000171	0.000445	CcSEcCtD
Leflunomide—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00017	0.000444	CcSEcCtD
Leflunomide—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.00017	0.00146	CbGpPWpGaD
Leflunomide—Diarrhoea—Mesalazine—ulcerative colitis	0.00017	0.000442	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—JAK2—ulcerative colitis	0.000169	0.00145	CbGpPWpGaD
Leflunomide—Dry mouth—Triamcinolone—ulcerative colitis	0.000169	0.000442	CcSEcCtD
Leflunomide—Angioedema—Betamethasone—ulcerative colitis	0.000169	0.00044	CcSEcCtD
Leflunomide—Angioedema—Dexamethasone—ulcerative colitis	0.000169	0.00044	CcSEcCtD
Leflunomide—Anorexia—Hydrocortisone—ulcerative colitis	0.000168	0.000438	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—SEL1L—ulcerative colitis	0.000167	0.00143	CbGpPWpGaD
Leflunomide—Immune system disorder—Prednisone—ulcerative colitis	0.000167	0.000435	CcSEcCtD
Leflunomide—Malaise—Betamethasone—ulcerative colitis	0.000166	0.000434	CcSEcCtD
Leflunomide—Malaise—Dexamethasone—ulcerative colitis	0.000166	0.000434	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNG—ulcerative colitis	0.000166	0.00142	CbGpPWpGaD
Leflunomide—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000166	0.000433	CcSEcCtD
Leflunomide—Vertigo—Betamethasone—ulcerative colitis	0.000166	0.000432	CcSEcCtD
Leflunomide—Vertigo—Dexamethasone—ulcerative colitis	0.000166	0.000432	CcSEcCtD
Leflunomide—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000166	0.000432	CcSEcCtD
Leflunomide—Arrhythmia—Prednisone—ulcerative colitis	0.000165	0.00043	CcSEcCtD
Leflunomide—Infection—Triamcinolone—ulcerative colitis	0.000165	0.00043	CcSEcCtD
Leflunomide—Hypotension—Hydrocortisone—ulcerative colitis	0.000165	0.00043	CcSEcCtD
Leflunomide—Infection—Methylprednisolone—ulcerative colitis	0.000165	0.000429	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—RELA—ulcerative colitis	0.000164	0.0014	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IRF5—ulcerative colitis	0.000164	0.0014	CbGpPWpGaD
Leflunomide—Dizziness—Mesalazine—ulcerative colitis	0.000164	0.000428	CcSEcCtD
Leflunomide—Insomnia—Prednisolone—ulcerative colitis	0.000163	0.000426	CcSEcCtD
Leflunomide—Alopecia—Prednisone—ulcerative colitis	0.000163	0.000425	CcSEcCtD
Leflunomide—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000162	0.000424	CcSEcCtD
Leflunomide—Paraesthesia—Prednisolone—ulcerative colitis	0.000162	0.000423	CcSEcCtD
Leflunomide—Tachycardia—Triamcinolone—ulcerative colitis	0.000162	0.000422	CcSEcCtD
Leflunomide—Mental disorder—Prednisone—ulcerative colitis	0.000162	0.000422	CcSEcCtD
Leflunomide—Nausea—Azathioprine—ulcerative colitis	0.000162	0.000422	CcSEcCtD
Leflunomide—Tachycardia—Methylprednisolone—ulcerative colitis	0.000162	0.000422	CcSEcCtD
Leflunomide—Skin disorder—Methylprednisolone—ulcerative colitis	0.000161	0.00042	CcSEcCtD
Leflunomide—Malnutrition—Prednisone—ulcerative colitis	0.000161	0.000419	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000161	0.000419	CcSEcCtD
Leflunomide—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.00016	0.000418	CcSEcCtD
Leflunomide—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.00016	0.000418	CcSEcCtD
Leflunomide—Insomnia—Hydrocortisone—ulcerative colitis	0.000159	0.000416	CcSEcCtD
Leflunomide—Hypertension—Dexamethasone—ulcerative colitis	0.000159	0.000416	CcSEcCtD
Leflunomide—Hypertension—Betamethasone—ulcerative colitis	0.000159	0.000416	CcSEcCtD
Leflunomide—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000158	0.000413	CcSEcCtD
Leflunomide—Vomiting—Mesalazine—ulcerative colitis	0.000158	0.000411	CcSEcCtD
Leflunomide—Myalgia—Dexamethasone—ulcerative colitis	0.000157	0.00041	CcSEcCtD
Leflunomide—Myalgia—Betamethasone—ulcerative colitis	0.000157	0.00041	CcSEcCtD
Leflunomide—PTK2B—Immune System—CCR6—ulcerative colitis	0.000157	0.00134	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IRF8—ulcerative colitis	0.000157	0.00134	CbGpPWpGaD
Leflunomide—Anxiety—Dexamethasone—ulcerative colitis	0.000157	0.000408	CcSEcCtD
Leflunomide—Anxiety—Betamethasone—ulcerative colitis	0.000157	0.000408	CcSEcCtD
Leflunomide—Rash—Mesalazine—ulcerative colitis	0.000156	0.000408	CcSEcCtD
Leflunomide—Dermatitis—Mesalazine—ulcerative colitis	0.000156	0.000407	CcSEcCtD
Leflunomide—Headache—Mesalazine—ulcerative colitis	0.000155	0.000405	CcSEcCtD
Leflunomide—Discomfort—Betamethasone—ulcerative colitis	0.000155	0.000405	CcSEcCtD
Leflunomide—Discomfort—Dexamethasone—ulcerative colitis	0.000155	0.000405	CcSEcCtD
Leflunomide—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000155	0.000405	CcSEcCtD
Leflunomide—Hypotension—Methylprednisolone—ulcerative colitis	0.000155	0.000404	CcSEcCtD
Leflunomide—Pain—Prednisolone—ulcerative colitis	0.000154	0.000403	CcSEcCtD
Leflunomide—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000153	0.0004	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000152	0.000397	CcSEcCtD
Leflunomide—Fatigue—Hydrocortisone—ulcerative colitis	0.000152	0.000396	CcSEcCtD
Leflunomide—Vision blurred—Prednisone—ulcerative colitis	0.000151	0.000395	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000151	0.000394	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000151	0.000394	CcSEcCtD
Leflunomide—Pain—Hydrocortisone—ulcerative colitis	0.000151	0.000393	CcSEcCtD
Leflunomide—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000151	0.000393	CcSEcCtD
Leflunomide—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000151	0.000393	CcSEcCtD
Leflunomide—Insomnia—Triamcinolone—ulcerative colitis	0.00015	0.000392	CcSEcCtD
Leflunomide—Insomnia—Methylprednisolone—ulcerative colitis	0.00015	0.000391	CcSEcCtD
Leflunomide—Infection—Betamethasone—ulcerative colitis	0.00015	0.00039	CcSEcCtD
Leflunomide—Infection—Dexamethasone—ulcerative colitis	0.00015	0.00039	CcSEcCtD
Leflunomide—PTK2B—Immune System—FCGR2A—ulcerative colitis	0.000149	0.00128	CbGpPWpGaD
Leflunomide—Ill-defined disorder—Prednisone—ulcerative colitis	0.000149	0.000389	CcSEcCtD
Leflunomide—Paraesthesia—Triamcinolone—ulcerative colitis	0.000149	0.000389	CcSEcCtD
Leflunomide—Feeling abnormal—Prednisolone—ulcerative colitis	0.000149	0.000388	CcSEcCtD
Leflunomide—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000149	0.000388	CcSEcCtD
Leflunomide—Anaemia—Prednisone—ulcerative colitis	0.000149	0.000387	CcSEcCtD
Leflunomide—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000149	0.00127	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	0.000148	0.00127	CbGpPWpGaD
Leflunomide—Dyspnoea—Triamcinolone—ulcerative colitis	0.000148	0.000386	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL2—ulcerative colitis	0.000148	0.00126	CbGpPWpGaD
Leflunomide—Nervous system disorder—Betamethasone—ulcerative colitis	0.000148	0.000385	CcSEcCtD
Leflunomide—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000148	0.000385	CcSEcCtD
Leflunomide—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000147	0.000385	CcSEcCtD
Leflunomide—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000147	0.000385	CcSEcCtD
Leflunomide—Nausea—Mesalazine—ulcerative colitis	0.000147	0.000384	CcSEcCtD
Leflunomide—DHODH—Metabolism—PPARG—ulcerative colitis	0.000147	0.00126	CbGpPWpGaD
Leflunomide—Tachycardia—Betamethasone—ulcerative colitis	0.000147	0.000383	CcSEcCtD
Leflunomide—Tachycardia—Dexamethasone—ulcerative colitis	0.000147	0.000383	CcSEcCtD
Leflunomide—Angioedema—Prednisone—ulcerative colitis	0.000147	0.000383	CcSEcCtD
Leflunomide—Dyspepsia—Triamcinolone—ulcerative colitis	0.000146	0.000381	CcSEcCtD
Leflunomide—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000146	0.00038	CcSEcCtD
Leflunomide—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000146	0.00038	CcSEcCtD
Leflunomide—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000146	0.00038	CcSEcCtD
Leflunomide—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000145	0.000379	CcSEcCtD
Leflunomide—Malaise—Prednisone—ulcerative colitis	0.000145	0.000378	CcSEcCtD
Leflunomide—Vertigo—Prednisone—ulcerative colitis	0.000144	0.000377	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	0.000144	0.00123	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000144	0.000376	CcSEcCtD
Leflunomide—Anorexia—Betamethasone—ulcerative colitis	0.000144	0.000374	CcSEcCtD
Leflunomide—Anorexia—Dexamethasone—ulcerative colitis	0.000144	0.000374	CcSEcCtD
Leflunomide—Urticaria—Prednisolone—ulcerative colitis	0.000143	0.000374	CcSEcCtD
Leflunomide—PTK2B—Immune System—PTPN2—ulcerative colitis	0.000143	0.00123	CbGpPWpGaD
Leflunomide—Fatigue—Triamcinolone—ulcerative colitis	0.000143	0.000373	CcSEcCtD
Leflunomide—Fatigue—Methylprednisolone—ulcerative colitis	0.000143	0.000372	CcSEcCtD
Leflunomide—Pain—Triamcinolone—ulcerative colitis	0.000142	0.00037	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000142	0.00121	CbGpPWpGaD
Leflunomide—Hypotension—Betamethasone—ulcerative colitis	0.000141	0.000367	CcSEcCtD
Leflunomide—Hypotension—Dexamethasone—ulcerative colitis	0.000141	0.000367	CcSEcCtD
Leflunomide—Urticaria—Hydrocortisone—ulcerative colitis	0.00014	0.000365	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	0.00014	0.00119	CbGpPWpGaD
Leflunomide—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000139	0.000363	CcSEcCtD
Leflunomide—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000139	0.000363	CcSEcCtD
Leflunomide—Hypertension—Prednisone—ulcerative colitis	0.000139	0.000362	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	0.000138	0.00118	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCR1—ulcerative colitis	0.000138	0.00118	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000137	0.000358	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000137	0.000358	CcSEcCtD
Leflunomide—Arthralgia—Prednisone—ulcerative colitis	0.000137	0.000357	CcSEcCtD
Leflunomide—Myalgia—Prednisone—ulcerative colitis	0.000137	0.000357	CcSEcCtD
Leflunomide—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000137	0.000357	CcSEcCtD
Leflunomide—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000136	0.000356	CcSEcCtD
Leflunomide—Anxiety—Prednisone—ulcerative colitis	0.000136	0.000356	CcSEcCtD
Leflunomide—Insomnia—Dexamethasone—ulcerative colitis	0.000136	0.000355	CcSEcCtD
Leflunomide—Insomnia—Betamethasone—ulcerative colitis	0.000136	0.000355	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000136	0.000354	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	0.000136	0.00116	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000135	0.000353	CcSEcCtD
Leflunomide—Paraesthesia—Betamethasone—ulcerative colitis	0.000135	0.000353	CcSEcCtD
Leflunomide—Paraesthesia—Dexamethasone—ulcerative colitis	0.000135	0.000353	CcSEcCtD
Leflunomide—Discomfort—Prednisone—ulcerative colitis	0.000135	0.000353	CcSEcCtD
Leflunomide—Hypersensitivity—Prednisolone—ulcerative colitis	0.000133	0.000347	CcSEcCtD
Leflunomide—Dyspepsia—Betamethasone—ulcerative colitis	0.000133	0.000346	CcSEcCtD
Leflunomide—Dyspepsia—Dexamethasone—ulcerative colitis	0.000133	0.000346	CcSEcCtD
Leflunomide—DHODH—Metabolism—ALB—ulcerative colitis	0.000132	0.00113	CbGpPWpGaD
Leflunomide—Urticaria—Triamcinolone—ulcerative colitis	0.000132	0.000344	CcSEcCtD
Leflunomide—Urticaria—Methylprednisolone—ulcerative colitis	0.000132	0.000343	CcSEcCtD
Leflunomide—Body temperature increased—Triamcinolone—ulcerative colitis	0.000131	0.000342	CcSEcCtD
Leflunomide—Anaphylactic shock—Prednisone—ulcerative colitis	0.000131	0.000342	CcSEcCtD
Leflunomide—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000131	0.000341	CcSEcCtD
Leflunomide—Decreased appetite—Betamethasone—ulcerative colitis	0.000131	0.000341	CcSEcCtD
Leflunomide—Decreased appetite—Dexamethasone—ulcerative colitis	0.000131	0.000341	CcSEcCtD
Leflunomide—Infection—Prednisone—ulcerative colitis	0.00013	0.00034	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.00013	0.000339	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.00013	0.000339	CcSEcCtD
Leflunomide—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.00013	0.000339	CcSEcCtD
Leflunomide—Fatigue—Dexamethasone—ulcerative colitis	0.00013	0.000339	CcSEcCtD
Leflunomide—Fatigue—Betamethasone—ulcerative colitis	0.00013	0.000339	CcSEcCtD
Leflunomide—Pain—Betamethasone—ulcerative colitis	0.000129	0.000336	CcSEcCtD
Leflunomide—Pain—Dexamethasone—ulcerative colitis	0.000129	0.000336	CcSEcCtD
Leflunomide—Nervous system disorder—Prednisone—ulcerative colitis	0.000129	0.000335	CcSEcCtD
Leflunomide—Tachycardia—Prednisone—ulcerative colitis	0.000128	0.000334	CcSEcCtD
Leflunomide—Skin disorder—Prednisone—ulcerative colitis	0.000127	0.000332	CcSEcCtD
Leflunomide—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000127	0.00109	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000127	0.00108	CbGpPWpGaD
Leflunomide—Hyperhidrosis—Prednisone—ulcerative colitis	0.000127	0.000331	CcSEcCtD
Leflunomide—Asthenia—Hydrocortisone—ulcerative colitis	0.000126	0.00033	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000126	0.00108	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000126	0.00108	CbGpPWpGaD
Leflunomide—Anorexia—Prednisone—ulcerative colitis	0.000125	0.000326	CcSEcCtD
Leflunomide—Pruritus—Hydrocortisone—ulcerative colitis	0.000125	0.000325	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	0.000124	0.00106	CbGpPWpGaD
Leflunomide—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000124	0.000324	CcSEcCtD
Leflunomide—Feeling abnormal—Betamethasone—ulcerative colitis	0.000124	0.000324	CcSEcCtD
Leflunomide—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	0.000123	0.00105	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000123	0.000321	CcSEcCtD
Leflunomide—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000123	0.000321	CcSEcCtD
Leflunomide—PTK2B—Immune System—CALM3—ulcerative colitis	0.000122	0.00105	CbGpPWpGaD
Leflunomide—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000122	0.000319	CcSEcCtD
Leflunomide—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000122	0.000318	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCL20—ulcerative colitis	0.000121	0.00103	CbGpPWpGaD
Leflunomide—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000121	0.000315	CcSEcCtD
Leflunomide—PTK2B—Immune System—RIPK2—ulcerative colitis	0.00012	0.00103	CbGpPWpGaD
Leflunomide—Urticaria—Betamethasone—ulcerative colitis	0.00012	0.000312	CcSEcCtD
Leflunomide—Urticaria—Dexamethasone—ulcerative colitis	0.00012	0.000312	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.00012	0.000312	CcSEcCtD
Leflunomide—Dizziness—Prednisolone—ulcerative colitis	0.000119	0.000311	CcSEcCtD
Leflunomide—Asthenia—Triamcinolone—ulcerative colitis	0.000119	0.000311	CcSEcCtD
Leflunomide—Body temperature increased—Dexamethasone—ulcerative colitis	0.000119	0.00031	CcSEcCtD
Leflunomide—Abdominal pain—Betamethasone—ulcerative colitis	0.000119	0.00031	CcSEcCtD
Leflunomide—Abdominal pain—Dexamethasone—ulcerative colitis	0.000119	0.00031	CcSEcCtD
Leflunomide—Body temperature increased—Betamethasone—ulcerative colitis	0.000119	0.00031	CcSEcCtD
Leflunomide—Asthenia—Methylprednisolone—ulcerative colitis	0.000119	0.00031	CcSEcCtD
Leflunomide—PTK2B—Immune System—CTLA4—ulcerative colitis	0.000119	0.00102	CbGpPWpGaD
Leflunomide—Insomnia—Prednisone—ulcerative colitis	0.000119	0.000309	CcSEcCtD
Leflunomide—Paraesthesia—Prednisone—ulcerative colitis	0.000118	0.000307	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	0.000118	0.00101	CbGpPWpGaD
Leflunomide—Pruritus—Triamcinolone—ulcerative colitis	0.000117	0.000306	CcSEcCtD
Leflunomide—Pruritus—Methylprednisolone—ulcerative colitis	0.000117	0.000306	CcSEcCtD
Leflunomide—ABCG2—Metabolism—CHP1—ulcerative colitis	0.000117	0.001	CbGpPWpGaD
Leflunomide—Dizziness—Hydrocortisone—ulcerative colitis	0.000117	0.000304	CcSEcCtD
Leflunomide—DHODH—Metabolism—PTGS2—ulcerative colitis	0.000116	0.000989	CbGpPWpGaD
Leflunomide—Dyspepsia—Prednisone—ulcerative colitis	0.000115	0.000301	CcSEcCtD
Leflunomide—Decreased appetite—Prednisone—ulcerative colitis	0.000114	0.000297	CcSEcCtD
Leflunomide—Rash—Prednisolone—ulcerative colitis	0.000114	0.000297	CcSEcCtD
Leflunomide—Dermatitis—Prednisolone—ulcerative colitis	0.000114	0.000297	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—GNA12—ulcerative colitis	0.000114	0.000972	CbGpPWpGaD
Leflunomide—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000113	0.000296	CcSEcCtD
Leflunomide—PTK2B—Immune System—CD79A—ulcerative colitis	0.000113	0.000969	CbGpPWpGaD
Leflunomide—Fatigue—Prednisone—ulcerative colitis	0.000113	0.000295	CcSEcCtD
Leflunomide—Headache—Prednisolone—ulcerative colitis	0.000113	0.000295	CcSEcCtD
Leflunomide—Constipation—Prednisone—ulcerative colitis	0.000112	0.000293	CcSEcCtD
Leflunomide—Vomiting—Hydrocortisone—ulcerative colitis	0.000112	0.000292	CcSEcCtD
Leflunomide—Rash—Hydrocortisone—ulcerative colitis	0.000111	0.00029	CcSEcCtD
Leflunomide—Dermatitis—Hydrocortisone—ulcerative colitis	0.000111	0.00029	CcSEcCtD
Leflunomide—Headache—Hydrocortisone—ulcerative colitis	0.00011	0.000288	CcSEcCtD
Leflunomide—Dizziness—Triamcinolone—ulcerative colitis	0.00011	0.000286	CcSEcCtD
Leflunomide—Dizziness—Methylprednisolone—ulcerative colitis	0.00011	0.000286	CcSEcCtD
Leflunomide—PTK2B—Immune System—NOD2—ulcerative colitis	0.000109	0.000934	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD14—ulcerative colitis	0.000109	0.000929	CbGpPWpGaD
Leflunomide—Feeling abnormal—Prednisone—ulcerative colitis	0.000108	0.000282	CcSEcCtD
Leflunomide—Asthenia—Betamethasone—ulcerative colitis	0.000108	0.000282	CcSEcCtD
Leflunomide—Asthenia—Dexamethasone—ulcerative colitis	0.000108	0.000282	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CXCR2—ulcerative colitis	0.000108	0.000922	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000107	0.00028	CcSEcCtD
Leflunomide—Nausea—Prednisolone—ulcerative colitis	0.000107	0.00028	CcSEcCtD
Leflunomide—Pruritus—Dexamethasone—ulcerative colitis	0.000107	0.000278	CcSEcCtD
Leflunomide—Pruritus—Betamethasone—ulcerative colitis	0.000107	0.000278	CcSEcCtD
Leflunomide—Vomiting—Triamcinolone—ulcerative colitis	0.000106	0.000275	CcSEcCtD
Leflunomide—Vomiting—Methylprednisolone—ulcerative colitis	0.000105	0.000275	CcSEcCtD
Leflunomide—PTK2B—Immune System—VCAM1—ulcerative colitis	0.000105	0.000897	CbGpPWpGaD
Leflunomide—Nausea—Hydrocortisone—ulcerative colitis	0.000105	0.000273	CcSEcCtD
Leflunomide—Rash—Triamcinolone—ulcerative colitis	0.000105	0.000273	CcSEcCtD
Leflunomide—Dermatitis—Triamcinolone—ulcerative colitis	0.000105	0.000273	CcSEcCtD
Leflunomide—PTK2B—Immune System—HLA-DQA1—ulcerative colitis	0.000105	0.000894	CbGpPWpGaD
Leflunomide—Rash—Methylprednisolone—ulcerative colitis	0.000104	0.000272	CcSEcCtD
Leflunomide—Dermatitis—Methylprednisolone—ulcerative colitis	0.000104	0.000272	CcSEcCtD
Leflunomide—Urticaria—Prednisone—ulcerative colitis	0.000104	0.000272	CcSEcCtD
Leflunomide—Headache—Triamcinolone—ulcerative colitis	0.000104	0.000271	CcSEcCtD
Leflunomide—Headache—Methylprednisolone—ulcerative colitis	0.000104	0.000271	CcSEcCtD
Leflunomide—Abdominal pain—Prednisone—ulcerative colitis	0.000104	0.00027	CcSEcCtD
Leflunomide—Body temperature increased—Prednisone—ulcerative colitis	0.000104	0.00027	CcSEcCtD
Leflunomide—Diarrhoea—Betamethasone—ulcerative colitis	0.000103	0.000269	CcSEcCtD
Leflunomide—Diarrhoea—Dexamethasone—ulcerative colitis	0.000103	0.000269	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCR6—ulcerative colitis	0.000101	0.000866	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—DLD—ulcerative colitis	0.000101	0.000864	CbGpPWpGaD
Leflunomide—Dizziness—Dexamethasone—ulcerative colitis	9.96e-05	0.00026	CcSEcCtD
Leflunomide—Dizziness—Betamethasone—ulcerative colitis	9.96e-05	0.00026	CcSEcCtD
Leflunomide—Nausea—Triamcinolone—ulcerative colitis	9.86e-05	0.000257	CcSEcCtD
Leflunomide—Nausea—Methylprednisolone—ulcerative colitis	9.84e-05	0.000257	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	9.81e-05	0.000839	CbGpPWpGaD
Leflunomide—Hypersensitivity—Prednisone—ulcerative colitis	9.66e-05	0.000252	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—MAML2—ulcerative colitis	9.6e-05	0.000821	CbGpPWpGaD
Leflunomide—Vomiting—Betamethasone—ulcerative colitis	9.58e-05	0.00025	CcSEcCtD
Leflunomide—Vomiting—Dexamethasone—ulcerative colitis	9.58e-05	0.00025	CcSEcCtD
Leflunomide—Rash—Betamethasone—ulcerative colitis	9.5e-05	0.000248	CcSEcCtD
Leflunomide—Rash—Dexamethasone—ulcerative colitis	9.5e-05	0.000248	CcSEcCtD
Leflunomide—Dermatitis—Betamethasone—ulcerative colitis	9.49e-05	0.000247	CcSEcCtD
Leflunomide—Dermatitis—Dexamethasone—ulcerative colitis	9.49e-05	0.000247	CcSEcCtD
Leflunomide—Headache—Betamethasone—ulcerative colitis	9.44e-05	0.000246	CcSEcCtD
Leflunomide—Headache—Dexamethasone—ulcerative colitis	9.44e-05	0.000246	CcSEcCtD
Leflunomide—Asthenia—Prednisone—ulcerative colitis	9.41e-05	0.000245	CcSEcCtD
Leflunomide—Pruritus—Prednisone—ulcerative colitis	9.28e-05	0.000242	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	9.16e-05	0.000783	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	9.16e-05	0.000783	CbGpPWpGaD
Leflunomide—Diarrhoea—Prednisone—ulcerative colitis	8.98e-05	0.000234	CcSEcCtD
Leflunomide—Nausea—Dexamethasone—ulcerative colitis	8.95e-05	0.000233	CcSEcCtD
Leflunomide—Nausea—Betamethasone—ulcerative colitis	8.95e-05	0.000233	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—PTGER4—ulcerative colitis	8.92e-05	0.000763	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ADCY5—ulcerative colitis	8.87e-05	0.000759	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—ulcerative colitis	8.68e-05	0.000743	CbGpPWpGaD
Leflunomide—Dizziness—Prednisone—ulcerative colitis	8.67e-05	0.000226	CcSEcCtD
Leflunomide—Vomiting—Prednisone—ulcerative colitis	8.34e-05	0.000217	CcSEcCtD
Leflunomide—Rash—Prednisone—ulcerative colitis	8.27e-05	0.000216	CcSEcCtD
Leflunomide—Dermatitis—Prednisone—ulcerative colitis	8.26e-05	0.000215	CcSEcCtD
Leflunomide—Headache—Prednisone—ulcerative colitis	8.22e-05	0.000214	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—GHRL—ulcerative colitis	8.17e-05	0.000698	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CALM3—ulcerative colitis	7.91e-05	0.000676	CbGpPWpGaD
Leflunomide—Nausea—Prednisone—ulcerative colitis	7.79e-05	0.000203	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—RIPK2—ulcerative colitis	7.79e-05	0.000666	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CRP—ulcerative colitis	7.76e-05	0.000664	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TLR4—ulcerative colitis	7.44e-05	0.000637	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DRB1—ulcerative colitis	7.44e-05	0.000636	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	7.3e-05	0.000624	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ICAM1—ulcerative colitis	7.14e-05	0.00061	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.81e-05	0.000583	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRB2—ulcerative colitis	6.76e-05	0.000578	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CDH1—ulcerative colitis	6.31e-05	0.00054	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CHP1—ulcerative colitis	5.91e-05	0.000506	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADCY5—ulcerative colitis	5.74e-05	0.000491	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.54e-05	0.000474	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—JAK2—ulcerative colitis	5.53e-05	0.000473	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNG—ulcerative colitis	5.43e-05	0.000464	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—RELA—ulcerative colitis	5.36e-05	0.000458	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD4—ulcerative colitis	5.24e-05	0.000449	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DLD—ulcerative colitis	5.1e-05	0.000436	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CHP1—ulcerative colitis	5.05e-05	0.000432	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS1—ulcerative colitis	4.88e-05	0.000418	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—ulcerative colitis	4.84e-05	0.000414	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL2—ulcerative colitis	4.83e-05	0.000413	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.73e-05	0.000405	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.57e-05	0.000391	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—NFKB1—ulcerative colitis	4.52e-05	0.000386	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CALM3—ulcerative colitis	4.4e-05	0.000376	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DLD—ulcerative colitis	4.36e-05	0.000373	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—STAT3—ulcerative colitis	4.06e-05	0.000347	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—JAK2—ulcerative colitis	3.58e-05	0.000306	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RELA—ulcerative colitis	3.46e-05	0.000296	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ABCB1—ulcerative colitis	3.42e-05	0.000292	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL8—ulcerative colitis	3.26e-05	0.000279	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADCY5—ulcerative colitis	3.19e-05	0.000273	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2—ulcerative colitis	3.12e-05	0.000267	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP9—ulcerative colitis	2.95e-05	0.000253	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NFKB1—ulcerative colitis	2.92e-05	0.00025	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—ulcerative colitis	2.84e-05	0.000243	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.7e-05	0.000231	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—STAT3—ulcerative colitis	2.63e-05	0.000225	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS1—ulcerative colitis	2.47e-05	0.000211	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TGFB1—ulcerative colitis	2.43e-05	0.000208	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.43e-05	0.000207	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARG—ulcerative colitis	2.38e-05	0.000203	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.31e-05	0.000197	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.22e-05	0.00019	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—ulcerative colitis	2.14e-05	0.000183	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.12e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS1—ulcerative colitis	2.11e-05	0.00018	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.07e-05	0.000177	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TP53—ulcerative colitis	2e-05	0.000171	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CALM3—ulcerative colitis	1.9e-05	0.000162	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—ulcerative colitis	1.87e-05	0.00016	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—ulcerative colitis	1.83e-05	0.000157	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.81e-05	0.000155	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.73e-05	0.000148	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.61e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCB1—ulcerative colitis	1.48e-05	0.000126	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADCY5—ulcerative colitis	1.38e-05	0.000118	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.2e-05	0.000103	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—ulcerative colitis	1.08e-05	9.24e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.03e-05	8.78e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—ulcerative colitis	9.45e-06	8.08e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—ulcerative colitis	9.23e-06	7.9e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—ulcerative colitis	8.08e-06	6.91e-05	CbGpPWpGaD
